Compounded GLP-1s are not FDA-approved
Kato, Promotion of cellular senescence by THG-1/TSC22D4 knockout through activation of JUNB
The peptide does not act as a stimulant or affect the central nervous system in ways that impair sleep
15 GPx links two GSH molecules through a disulfide bridge to form GSSG and, during this process, H 2 O 2 is reduced to water and lipid hydroperoxides to their corresponding alcohols
**BPC-157, a synthetic gastric pentadecapeptide studied primarily in animal models for tissue repair, gut healing, and anti-inflammatory effects, remains unapproved by the FDA as a finished drug with only limited small-scale human data available.** It was placed in Category 2 in 2023 due to concerns over immunogenicity, peptide impurities, and insufficient safety information for compounding under Section 503A
Shares of both companies declined on Tuesday, underperforming the broader S&P 500, following the announcement